Antibiotic Resistance among Fusobacterium, Capnocytophaga, and Leptotrichia Species of the Oral Cavity

PURPOSE: Antibiotics play an important role in treating periodontal diseases. Due to the effectiveness of antibiotic therapies, their usage in dentistry has significantly increased. The aim of this study focused on the in-vitro susceptibility of different gram-negative oral bacteria species - which are associated with periodontal diseases (Fusobacterium spp., Capnocytophaga spp. and Leptotrichia buccalis) and have different geographical origins (Asia and Europe) - against antimicrobials that are clinically relevant in dental therapy.

MATERIALS AND METHODS: A total of 45 strains were tested (29 Fusobacterium spp., 13 Capnocytophaga spp. and 3 L. buccalis) that were either isolated from Chinese patients or were obtained from different strain collections. Their antimicrobial susceptibility to the antimicrobial agents benzylpenicillin, amoxicillin, amoxicillin-clavulanic acid, ciprofloxacin, moxifloxacin, clindamycin, doxycycline, tetracycline and metronidazole was tested using the E-Test. Strains with particular resistance to penicillin, clindamycin and metronidazole were further analysed for resistance genes.

RESULTS: All tested bacterial isolates were sensitive to amoxicillin, amoxicillin-clavulanic acid, doxycycline and tetracycline, but showed variable sensitivity towards other antibiotics such as benzylpenicillin, ciprofloxacin, moxifloxacin, clindamycin and metronidazole.

CONCLUSION: The results of the present study suggest that certain periodontal disease-related bacterial strains can be resistant towards antimicrobial agents commonly used in adjuvant periodontal therapy.

Medienart:

E-Artikel

Erscheinungsjahr:

2023

Erschienen:

2023

Enthalten in:

Zur Gesamtaufnahme - volume:21

Enthalten in:

Oral health & preventive dentistry - 21(2023) vom: 04. Apr., Seite 93-102

Sprache:

Englisch

Beteiligte Personen:

Thurnheer, Thomas [VerfasserIn]
Bensland, Sabrina [VerfasserIn]
Eick, Sigrun [VerfasserIn]
Kulik, Eva M [VerfasserIn]
Attin, Thomas [VerfasserIn]
Karygianni, Lamprini [VerfasserIn]

Links:

Volltext

Themen:

140QMO216E
3U02EL437C
5E8K9I0O4U
74469-00-4
804826J2HU
Amoxicillin
Amoxicillin-Potassium Clavulanate Combination
Anti-Bacterial Agents
Anti-Infective Agents
Antibiotics
Ciprofloxacin
Clindamycin
Clinical isolates
Doxycycline
E-test
Journal Article
Metronidazole
Moxifloxacin
N12000U13O
Oral bacteria
Resistance
U188XYD42P

Anmerkungen:

Date Completed 06.04.2023

Date Revised 25.04.2024

published: Electronic

Citation Status MEDLINE

doi:

10.3290/j.ohpd.b4009553

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM355189828